Slide 1 IL-17a blockade and the treatment of psoriasis K. Alexander Papp MD, PhD, FRCPC Probity Medical Research, Canada (US, Australia, Chile) ‹#› Psoriasis Perspective…

Cancer Immunotherapy! Shr-Uen Lin ! 2014.10.20 1 An-Li Cheng, NTUH2 Why immunotherapy? Klaus&F&Rabe&et&al,&2012&Lancet.� 3 Why immunotherapy? Target'therapy'with'mul0ple1or1no'drivers??�4…

Virulence Factor-Based Drug Discovery A Novel Approach for Identifying Drug Targets for Autoimmune and Inflammatory Diseases David Bienvenue, Ph.D. VLST Corporation Viral…

Presentation for Red Chip January 28, 2015 NASDAQ: GALT www.galectintherapeutics.com © 2015 Galectin Therapeutics Inc. 2© 2015 Galectin Therapeutics | NASDAQ:GALT This…

Diapositiva 1 Inmunidad mediada por linfocitos B: inducción de anticuerpos Adriana Gruppi [email protected] Distribución de linfocitos B en OLS Cooperación T-B :…

1. Expression and Purification of Virulence Factors A Novel Approach for Identifying Drug Targets for Autoimmune and Inflammatory Diseases David Bienvenue, Ph.D. VLST Corporation…

1. 1Is One R the new Three Rs?Lisbeth E. KnudsenProfessor, PhD, University of Copenhagen, Department of Public [email protected] MathiesenThit Aarøe MørckPernille…

Slide 1 www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 The impact of SIV infection on gut innate lymphocyte populations and gene expression Ronald S. Veazey,…

Slide 1 When B Cells Go Bad: Infection, Inflammation and Chronic B Cell Stimulation Karen S. Anderson MD PhD Associate Professor, Biodesign Institute Arizona State University…

Slide 1 M. Carrie Miceli May 4, 2005 TCR Signal Transduction and Membrane Dynamics Reading Huppa, J. B., Davis, M. M. T-cell-antigen recognition and the immunological synapse.…